Researchers in the Division of Medical Oncology are nationally and internationally known for their work in cancer research. They collaborate with colleagues in their own division, institution and many institutions globally.
Our research focus centers on the development and application of experimental therapeutics and targeted agents for future cancer patient treatment. This includes testing new drugs in models systems starting with in-vitro cell culture and moving to in vivo models. New compounds are developed within the Division as well as through collaboration with pharmaceutical companies.
Our researchers continue to study the mechanisms of resistance developed over time by patients to certain drugs and also studies of the innate resistance in some patients to certain drugs are a central focus.
Many exciting strides are being made in the fight against cancer and we remain passionate in our quest to succeed in the battle.